FindTrial
Sign In

Finding the relation of ama with systemic inflammation in patients of metabolic syndrome

An observational study to analyze the relation of ama with systemic inflammation in relation to metabolic syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050588
Enrollment
40
Registered
2023-03-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E889- Metabolic disorder, unspecified

Interventions

None listed

Sponsors

Ayurvedic and Unani Tibbia College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: For group 1 Patients having mandagni according to Agni-bala assessment questionnaire For group 2 Patients having mandagni and having three or more following conditions present for enrollment According to the NCEP ATP III definition waist circumference over 40 inches (men) or 35 inches (women) blood pressure over 130/85 mmHg fasting triglyceride (TG) level over 150 mg/dl fasting high-density lipoprotein (HDL) cholesterol level less than 40 mg/dl (men) or 50 mg/dl (women) fasting blood sugar over 100 mg/dl

Exclusion criteria

Exclusion criteria: Individuals having teekshna, vishama or samagni. Currently pregnant or post-partum state or lactating women. Cancer patients Chronic kidney failure Any surgical intervention in the past 6 months

Design outcomes

Primary

MeasureTime frame
Assesment of Ama dosha on the basis of agni assessment questionnaireTimepoint: At baseline—

Secondary

MeasureTime frame
Assessment of the relation of Ama dosha and systemic inflammation via inflammatory markers Timepoint: At baseline—

Countries

India

Contacts

Public ContactDr Sujata Rajan

Ayurvedic and Unani Tibbia College and Hospital

sujataa.rajan@gmail.com9354925026

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026